Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder
- 1 August 2000
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 24 (6) , 881-888
- https://doi.org/10.1016/s0278-5846(00)00115-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neurotrophins and depressionTrends in Pharmacological Sciences, 1999
- Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophreniaNeuroscience Letters, 1998
- Increased temporal cortex CREB concentrations and antidepressant treatment in major depressionThe Lancet, 1998
- A Molecular and Cellular Theory of DepressionArchives of General Psychiatry, 1997
- Expression of the α1, α2 and α3 isoforms of the GABAA receptor in human alcoholic brainBrain Research, 1997
- Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampusJournal of Neuroscience, 1996
- Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatmentsJournal of Neuroscience, 1995
- The Trk family of neurotrophin receptorsJournal of Neurobiology, 1994
- Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Competitor mRNA fragments for quantitation of cytokine specific transcripts in cell lysatesMolecular Immunology, 1993